Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grups

Publicacions

  • Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X

    Endometrial carcinoma: molecular alterations involved in tumor development and progression

    ONCOGENE 32 403-413. .

    [doi:10.1038/onc.2012.76]

  • Grotsky, David A.; Gonzalez-Suarez, Ignacio; Novell, Anna; Neumann, Martin A.; Yaddanapudi, Sree C.; Croke, Monica; Martinez-Alonso, Montserrat; Redwood, Abena B.; Ortega-Martinez, Sylvia; Feng, Zhihui; Lerma, Enrique; Ramon y Cajal, Teresa; Zhang, Junran; Matias-Guiu, Xavier; Dusso, Adriana; Gonzalo, Susana

    BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells

    JOURNAL OF CELL BIOLOGY 200 187-202. .

    [doi:10.1083/jcb.201204053]

  • Vilardell, Felip; Matias-Guiu, X.

    CK19 expression should be tested prior to OSNA analysis of sentinel lymph nodes in breast cancer

    VIRCHOWS ARCHIV 462 121-121. .

    [doi:10.1007/s00428-012-1337-5]

  • Urdinguio, Rocio G.; Fernandez, Agustin F.; Moncada-Pazos, Angela; Huidobro, Covadonga; Rodriguez, Ramon M.; Ferrero, Cecilia; Martinez-Camblor, Pablo; Obaya, Alvaro J.; Bernal, Teresa; Parra-Blanco, Adolfo; Rodrigo, Luis; Santacana, Maria; Matias-Guiu, Xavier; Soldevilla, Beatriz; Dominguez, Gemma; Bonilla, Felix; Cal, Santiago; Lopez-Otin, Carlos; Fraga, Mario F.

    Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

    CANCER RESEARCH 73 395-405. .

    [doi:10.1158/0008-5472.CAN-12-0806]

  • Azueta, Ainara; Maiques, Oscar; Velasco, Ana; Santacana, Maria; Pallares, Judith; Novell, Anna; Llombart-Cussac, Antonio; Gonzalez-Tallada, Xavier; Mozos, Ana; Prat, Jaime; Pillai, Raji; Mata, Manuel; Matias-Guiu, Xavier

    Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin

    HUMAN PATHOLOGY 44 20-28. .

    [doi:10.1016/j.humpath.2012.04.018]

  • Matías-Guiu X.; Barriuso J.; Aranda I.; Capdevila J.; Cuatrecasas M.; González E.; González-Campora R.; Jiménez-Fonseca P.; Vilardell F.; García-Carbonero R.

    Recomendaciones para la Determinación de Biomarcadores en Tumores Endocrinos Gastroenteropancreáticos. Consenso nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica

    REVISTA ESPANOLA DE PATOLOGIA 46 222-236. .

    [doi:10.1016/j.patol.2013.06.004]

  • Matias-Guiu, Xavier; Prat, Jaime

    Molecular pathology of endometrial carcinoma

    Histopathology 62 111-123. .

    [doi:10.1111/his.12053]

  • Arjo, Gemma; Capell, Teresa; Matias-Guiu, Xavier; Zhu, Changfu; Christou, Paul; Pinol, Carme

    Mice fed on a diet enriched with genetically engineered multivitamin corn show no sub-acute toxic effects and no sub-chronic toxicity

    PLANT BIOTECHNOLOGY JOURNAL 10 1026-1034. .

    [doi:10.1111/j.1467-7652.2012.00730.x]

  • Colas, Eva; Pedrola, Nuria; Devis, Laura; Ertekin, Tugce; Campoy, Irene; Martinez, Elena; Llaurado, Marta; Rigau, Marina; Olivan, Mireia; Garcia, Marta; Cabrera, Silvia; Gil-Moreno, Antonio; Xercavins, Jordi; Castellvi, Josep; Garcia, Angel; Ramon y Cajal, Santiago; Moreno-Bueno, Gema; Dolcet, Xavier; Alameda, Francesc; Palacios, Jose; Prat, Jaime; Doll, Andreas; Matias-Guiu, Xavier; Abal, Miguel; Reventos, Jaume

    The EMT signaling pathways in endometrial carcinoma

    CLINICAL & TRANSLATIONAL ONCOLOGY 14 715-720. .

    [doi:10.1007/s12094-012-0866-3]

  • Sorolla, Anabel; Yeramian, Andree; Valls, Joan; Dolcet, Xavier; Bergada, Laura; Llombart-Cussac, Antoni; Maria Marti, Rosa; Matias-Guiu, Xavier

    Blockade of NF kappa B activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

    MOLECULAR ONCOLOGY 6 530-541. .

    [doi:10.1016/j.molonc.2012.06.006]

  • Armengol, AM; Susagna, MV; Gou-Fabregas, M; Santacana, M; VILARDELL, F; Matias-Guiu, X; Martin, ME

    Loss of Sprouty1 accelerates PTEN-induced tumor formation by suppressing cellular senescence

    FEBS Journal 279 167-167. .

  • Macia, A.; Gallel, P.; Vaquero, M.; Gou-Fabregas, M.; Santacana, M.; Maliszewska, A.; Robledo, M.; Gardiner, J. R.; Basson, M. A.; Matias-Guiu, X.; Encinas, M.

    Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

    ONCOGENE 31 3961-3972. .

    [doi:10.1038/onc.2011.556]

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU